November 2021; 8 (6) Views & ReviewsOpen Access
Remyelination Trials
Are We Expecting the Unexpected?
Alexandr Klistorner, Michael Barnett
First published August 10, 2021, DOI: https://doi.org/10.1212/NXI.0000000000001066
Alexandr Klistorner
From the Sydney University (A.K., M.B.); Maquarie University (A.K.); and Sydney Neuroimaging Analysis Center (M.B.), Australia.
PhDMichael Barnett
From the Sydney University (A.K., M.B.); Maquarie University (A.K.); and Sydney Neuroimaging Analysis Center (M.B.), Australia.
PhDRemyelination Trials
Are We Expecting the Unexpected?
Alexandr Klistorner, Michael Barnett
Neurol Neuroimmunol Neuroinflamm Nov 2021, 8 (6) e1066; DOI: 10.1212/NXI.0000000000001066
Citation Manager Formats
Make Comment
See Comments

Article Figures & Data
Tables
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Optical coherence tomography and disease subtype in multiple sclerosisM. Pulicken, E. Gordon-Lipkin, L. J. Balcer et al.Neurology, November 26, 2007 -
Article
Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritisYuyi You, Michael H. Barnett, Con Yiannikas et al.Neurology: Neuroimmunology & Neuroinflammation, March 13, 2020 -
Articles
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MSJorge Sepulcre, Manuel Murie-Fernandez, Angel Salinas-Alaman et al.Neurology, April 30, 2007 -
Article
No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MSMarco Pisa, Simone Guerrieri, Giovanni Di Maggio et al.Neurology, November 15, 2017